All In Biotech

Free tool

FAERS Monitor: Zipsor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022202 or its brand name (Zipsor, Diclofenac Potassium). Reports on generic versions are filed under their own applications.

Reports

9,031

Serious

8,021

89% of reports

Hospitalization

4,738

Death reported

4,371

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • rheumatoid arthritis2,666
  • fatigue2,566
  • rash2,500
  • drug ineffective2,493
  • systemic lupus erythematosus2,492
  • pain2,485
  • off label use2,475
  • joint swelling2,418
  • wound2,384
  • pemphigus2,316
  • glossodynia2,293
  • synovitis2,291
  • infusion related reaction2,266
  • hand deformity2,259
  • pericarditis2,248

Reports by year received

View as table
YearReports
20044
20059
200659
20079
200816
200915
201023
201173
201251
201355
201464
2015132
2016354
2017249
2018368
2019426
2020425
2021419
2022637
2023807
20242,030
20251,893
2026913

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,128 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal2,316529.2508.4995,232
hand deformitySignal2,259484.2465.1902,124
pericarditisSignal2,248359.6345.7696,659
synovitisSignal2,291338.8325.9673,912
glossodyniaSignal2,293265.6255.7543,022
woundSignal2,384217.1209.3469,439
systemic lupus erythematosusSignal2,492175.8169.7403,210
infusion related reactionSignal2,26682.479.4176,460
rheumatoid arthritisSignal2,66656.054.2141,291
joint swellingSignal2,41847.646.0108,646
rashSignal2,50013.413.029,185
painSignal2,4859.59.119,269
fatigueSignal2,5667.77.415,471
off label useSignal2,4756.66.412,227
drug ineffectiveSignal2,4934.44.37,001

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.